Influence of consensual protocols on the use of antibiotics and bacterial resistance in a general hospital. A prospective study 1995-2000;Influencia de la protocolización consensuada en el consumo de antibióticos y resistencias bacterianas en un hospital general. Estudio prospectivo 1995-2000

Revista Espanola de Quimioterapia

Volumn 16, Issue 3, 2003, Pages 289-294

  Gomez J ^a   Hernandez Cardona J L ^a   Simarro, E ^a   Ruiz Gomez J ^a   Gomez Vargas J ^a   San Miguel, M T ^b   Valdes M ^a   Canteras, M ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Bacterial resistance; Protocols; Use of antibiotics

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN; TAZOBACTAM; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG SENSITIVITY; DRUG UTILIZATION; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GENERAL HOSPITAL; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STATISTICAL SIGNIFICANCE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONSENSUS; HUMAN; SPAIN; STANDARD; STATISTICS;

ANTI-BACTERIAL AGENTS; CLINICAL PROTOCOLS; CONSENSUS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HOSPITALS, GENERAL; HUMANS; PROSPECTIVE STUDIES; SPAIN;

EID: 18844480437     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Harrison, J.W., Svec, T.A. The beginning of the end of the antibiotic era? Part-1. The problem: Abuse of the "miracle drugs ". Quintessence Int 1998; 29: 151-162.
2. Hart, C.A. Antibiotic resistance: And increasing problem? BMJ 1998; 316: 1255-1256.
3. Richet, H.M. Better antimicrobial resistanse surveillance efforts are hended. ASM News 2001; 67: 304-309.
4. Alós, J.A., Carnicero, M. Consumo de antibióticos y resistencia bacteriana a los antibióticos: "Algo que te concierne". Med Clin (Barc.) 1997; 109: 264-270.
5. Acar, J.F. Consequences of bacterial resistance to antibiotics in medical practice. Clin Infect Dis 1997; 24 (Suppl. 1): S17-S18.
6. Gaynes, R. The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Inf Dis Clin North Am 1997; 11: 757-765.
7. López Lozano, J.M., Monnet, D.L., Yagüe, A. y cols. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: A time series analysis. Int J Antimicrob Ag 2000; 14: 21-31.
8. Gómez, J. Valor de la racionalización en el uso clínico de antibióticos. An Med Intern (Madrid) 1998; 15: 334-337.
9. Drlica, K. A strategy for fighting antibiotic resistance. ASM News 2001; 67: 27-33.
10. Burke, J.P., Pstonik, S.L. Antibiotic resistance-systems thinking, chaos and complexity theory. Curr Opin Infect Dis 1999; 12: 317-319.
11. Goldman, D.A., Weinstein, R.A., Wenzel, R.P. y cols. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 1996; 275: 234-240.
12. Naber, K.G. Antibiotic resistance: Risk and strategies. Antibiotics Chemother 2000; 4: 1-3.
13. Harrison, J.W., Svec, T.A. The beginning of the end of the antibiotic era? Part-II. Proposed solution to antibiotic abuse. Quintessence Int 1998; 29: 223-229.
14. Thuong, M., Shortgen, F., Zazempa, V., Girou, E., Soussy, C.J., Brunbuisson, Ch. Appropiate use restricted antimicrobial agents in hospitals: The importance of empirical therapy and assited re-evaluation. J Antimicrob Chemother 2000; 46: 501-508.
15. Weinstein, R.A. Controlling antimicrobial resistance in hospitals: Infection control and use of antibiotics. Emerg Infect Dis 2001; 7: 188-192.
16. Yates, R.R. New intervention strategies for reducing antibiotic resistance. Chest 1999; 115: 24S-27S
17. Patterson, J.E. Antibiotic utilization: Is there and effect on antimicrobial resistance? Chest 2001; 119: 426S-430S.
18. Schmitz, F.J., Fluid, A.C. Mechanisms of resistance. En: Armstrong, D., Cohen, J. (Eds.). Infectious Diseases. Mosby, Harcourt Publishers, London 1999; 7: 2.1-2.14.
19. McKinnon, P.S., Freeman, C., Sougakoff, W. β-lactam and β-lactamase inhibitor combinations. En: Yu, V.L., Merigan, T.C. Jr., Barriere, S.L. (Eds.). Antimicrobial therapy and vaccines. Williams and Wilkins, Baltimore 1999; 676-690.
20. Yu, V.L., Patterson, D.L. Pseudomonas aeruginosa. En: Yu, V.L., Merigan, T.C. Jr., Barriere, S.L. (Eds.). Antimicrobial therapy and vaccines. Williams and Wilkins, Baltimore 1999; 348-358.
21. Monroe, S., Polk, R. Antimicrobial use and bacterial resistance. Curr Opin Microbiol 2000: 3: 496-501.
22. Bonhoeffer, S., Lipsitch, M., Levin, B. Evaluation treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA 1997; 94: 12106-12111.
23. Gómez, J. La antibioticoterapia del tercer milenio. Nuevos horizontes: ¿Mito o realidad? Rev Esp Quimioterap 2001; 14: 198-202.